A Gene Sequencing Pioneer Battles Over What It Can Buy
Is Illumina, a gene-sequencing powerhouse, trying to speed innovation in the field of cancer blood tests or thwart it with an acquisition? https://nyti.ms/3BcrnOq
The Orion capsule’s splashdown in the Pacific Ocean moved NASA into the next stages of the Artemis program, which will rely on Elon Musk’s rocket company to build a moon lander for astronauts. https://nyti.ms/3YcuUYn
Some of the industry’s critics are skeptical, however, about a new flexibility to changes to Section 230 of the Communications Decency Act. https://nyti.ms/34ey2si
A committee took its first vote in the early afternoon, advancing a bill that would increase the money companies pay government agencies when getting some mergers approved. https://nyti.ms/3d7WhN7
